All Type of News
Pfizer Korea to sue Kukje Pharm for amlodipine patent infringement
Pfizer Korea will likely to file a lawsuit against Kukje Pharm's amlodipine besylate generic for infringement of its Norvasc patent.
Pfizer Korea will seek a court injunction for kukje's Norvasc generic drug, accor...
Number of patent applications for nano-liposome drugs increases steadily
Nanotechnology has become a topic of widespread discussion amongst researchers, in the media, among the investment community and elsewhere. While there is certainly a degree of hyperbole in some of this enthusiasm, it...
Government to disclose overprescribing hospitals
The government plans to make public a list of hospitals and clinics overprescribing drugs to reduce unnecessary pill prescriptions in medical institutions, officials at the Health Insurance Review & Assessment Ser...
Korea's R&D spending to exceed 10 trillion won this year
The Ministry of Science and Technology says that the government is planning to spend around 10.8 trillion won on state-funded R& D projects this year, which is more than double the amount it spent in 2001, and a 10-pe...
Small package drug makers troubled by excessive stocks
The majority of small-packet pharmaceuticals remains in idle stock, according to data revealed by the Korea Pharmaceutical Manufacturers Association (KPMA).
The association found that of the 4,476 drugs in small pa...
Korean generic makers win Plavix patent lawsuit
Korea's 17 generic makers have won the right to market Plavix (clopidogrel bisulfate) as a local patent court ruled on January 18 that Sanofi-Aventis's original patent is already expired.
However, experts say that ...
Drug makers to vie for big pies over Plavix market
The country's generic makers will be in a fierce race to snatch up a bigger market share of Plavix (clopidogrel bisulfate) as the patent court has upheld that Korean makers' generic clopidogrel bisulfate does not infr...
Drug-related administration to be reformed
The Korea Food and Drug Administration says it is contemplating a series of new measures designed to ameliorate pharmaceuticals-related regulations.
Under its new plan, any venture firm will be allowed to obtain a ...
Norvasc price to lower 20% in January
The current drug price of Pfizer's Norvasc (amlodipine besylate) is likely to be reduced by 20 percent within this month, as its first generic version is covered by the national health insurance.
When a generic dru...
Kukje's first amlodipine generic gets 68% of original brand's price
Kukje Pharm said on January 21 that it has launched its amlodipine besylate 5 mg tablets at the insurance price of 355 won per tablet, a 68-percent price level of Norvasc.
Amlodipine besylate belongs to a group of ...
